D
Dyno Therapeutics
Utilizing next-gen DNA technologies and machine learning to engineer AAV capsids for effective delivery of gene therapies
About Dyno Therapeutics
Dyno Therapeutics is a biotech startup that is revolutionizing the gene therapy landscape through the use of Artificial Intelligence (AI). The company specializes in the creation of Adeno-associated virus (AAV) vectors, which are tools used in gene therapy to deliver genetic material into cells. Dyno's AI-powered technology allows for the creation of optimized AAV vectors, which have the potential to improve the effectiveness of gene therapies.
Read full description
The company operates in the biotech and healthcare market, serving pharmaceutical and biotech companies that are developing gene therapies. Notable clients include Astellas, Roche, Sarepta, and Novartis, with whom Dyno collaborates to develop improved gene therapies for various diseases, including those affecting the skeletal and cardiac muscles, the central nervous system (CNS), liver, and eyes.
Dyno's business model revolves around its proprietary AI technology, which it uses to design and optimize AAV vectors. The company generates revenue through partnerships with pharmaceutical and biotech companies, who use Dyno's AAV vectors in their gene therapy research and development.
The company has been recognized for its innovative work, being named one of the most promising startups of 2021 by Endpoints News, and Emerging Company of the Year by the New England Venture Capital Association. It has also been listed on Forbes' list of America's Best Startup Employers for two consecutive years.
At a glance
- Founded
- 2018
- Headquarters
- Watertown, United States
- Sector
- Biotech & Life Sciences
- Power Law
- Colt$25–100M revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed3 investors entered at this stage
KdT Ventures
Polaris Partners
CRV
Series A4 investors entered at this stage
Series B and later2 investors entered at this stage
- WIWyss Institute
- HUHarvard University
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about Dyno Therapeutics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Dyno Therapeutics on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.